No Detail Found!

Risk factors for post endoscopic retrograde cholangio pancreatography(ERCP) pancreatitis (PEP) and efficacy of octreotide in its prevention

Author(s)
Abdul Aleem Department of Medicine, Al Aleem Medical College, Ghulab Devi Teaching Hospital Lahore, Pakistan
Shahid Sarwar Department of Medicine, AIMC/ Jinnah Hospital, Lahore, Pakistan
Yasir Mahmud Department of Medicine, AIMC/ Jinnah Hospital, Lahore, Pakistan
Abstract
Background: Pancreatitis is a potentially fatal complication of ERCP, seen in 5-15% procedures. Factors precipitating its risk and effective pharmacological intervention for its prevention need exploration to improve patient safety. Objective: To identify risk factors for post-ERCP pancreatitis (PEP) and to determine efficacy of intravenous octreotide in preventing PEP. Methodology: A quasi-experimental triple blind placebo-based study included patients undergoing ERCP and randomize them in two groups through simple random sampling. Group A to receive intravenous Octreotide 4µg/kg before attempting cannulation during ERCP and 1cc N/S as placebo for group B. Patients were followed for PEP and data were analyzed using chi square (x2) and logistic regression analysis. Results: Of 203 included patients, 101 (49.3%) received octreotide while 102 (50.7%) were in control group. Post ERCP pancreatitis developed in 32 (15.8%) patients, in 8 (7.9%) patients of octreotide group while in 24 (23.8%) patients of control group (p value 0.002 with odds ratio (OR) for octreotide of 0.33 (95% CI 0.150.71). We identified biliary surgery (p value 0.005), serum bilirubin = 3 mg/dl (p value 0.03), cannulation time > 5 minutes (p value <0.000), needle knife sphincterotomy (p value 0.002), deep pancreatic duct (PD) cannulation (p value <0.000) and procedure time>30 minutes (p value 0.002) as risk factors for PEP. Conclusion: Previous biliary surgery, high serum bilirubin, cannulation time > 5 minutes, use of needle knife, PD cannulation and procedure time > 30 minutes are associated with increased risk of PEP. Intravenous octreotide before cannulation reduces risk of post ERCP pancreatitis.
Publication Details
Page(s) 387-392
DOI DOI not available
Published Journal: Annals of King Edward Medical University, Volume: 28, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
Pancreatitis, Risk Factors, ERCP, Octreotide
0

Citations

0

Downloads

31

Views